492 related articles for article (PubMed ID: 28902875)
1. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
3. Rab27a Contributes to Cathepsin S Secretion in Lacrimal Gland Acinar Cells.
Fu R; Edman MC; Hamm-Alvarez SF
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562815
[TBL] [Abstract][Full Text] [Related]
4. Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome.
Meng Z; Edman MC; Hsueh PY; Chen CY; Klinngam W; Tolmachova T; Okamoto CT; Hamm-Alvarez SF
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C942-54. PubMed ID: 27076615
[TBL] [Abstract][Full Text] [Related]
5. Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjögren's syndrome.
Chen FY; Lee A; Ge S; Nathan S; Knox SM; McNamara NA
PLoS One; 2017; 12(9):e0184916. PubMed ID: 28926640
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin S activation contributes to elevated CX3CL1 (fractalkine) levels in tears of a Sjögren's syndrome murine model.
Fu R; Guo H; Janga S; Choi M; Klinngam W; Edman MC; Hamm-Alvarez SF
Sci Rep; 2020 Jan; 10(1):1455. PubMed ID: 31996771
[TBL] [Abstract][Full Text] [Related]
7. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor inhibitor gene expression suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis.
Zhu Z; Stevenson D; Schechter JE; Mircheff AK; Crow RW; Atkinson R; Ritter T; Bose S; Trousdale MD
Cornea; 2003 May; 22(4):343-51. PubMed ID: 12792478
[TBL] [Abstract][Full Text] [Related]
10. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
[TBL] [Abstract][Full Text] [Related]
11. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
Johnson BC; Morton JI; Trune DR
Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice.
Kong L; Robinson CP; Peck AB; Vela-Roch N; Sakata KM; Dang H; Talal N; Humphreys-Beher MG
Clin Exp Rheumatol; 1998; 16(6):675-81. PubMed ID: 9844759
[TBL] [Abstract][Full Text] [Related]
13. Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development.
da Costa SR; Wu K; Veigh MM; Pidgeon M; Ding C; Schechter JE; Hamm-Alvarez SF
Exp Eye Res; 2006 Jan; 82(1):33-45. PubMed ID: 16005870
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjögren's Syndrome.
Janga SR; Shah M; Ju Y; Meng Z; Edman MC; Hamm-Alvarez SF
Biomarkers; 2019 Feb; 24(1):91-102. PubMed ID: 30126300
[TBL] [Abstract][Full Text] [Related]
15. Arginase 1 is involved in lacrimal hyposecretion in male NOD mice, a model of Sjögren's syndrome, regardless of dacryoadenitis status.
Ohno Y; Satoh K; Shitara A; Into T; Kashimata M
J Physiol; 2020 Nov; 598(21):4907-4925. PubMed ID: 32780506
[TBL] [Abstract][Full Text] [Related]
16. Phenylephrine increases tear cathepsin S secretion in healthy murine lacrimal gland acinar cells through an alternative secretory pathway.
Fu R; Janga S; Edman MC; Hamm-Alvarez SF
Exp Eye Res; 2021 Oct; 211():108760. PubMed ID: 34487726
[TBL] [Abstract][Full Text] [Related]
17. CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren syndrome.
Barr JY; Wang X; Meyerholz DK; Lieberman SM
Immunol Cell Biol; 2017 Sep; 95(8):684-694. PubMed ID: 28465508
[TBL] [Abstract][Full Text] [Related]
18. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.
Jabs DA; Lee B; Whittum-Hudson JA; Prendergast RA
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):826-31. PubMed ID: 10711700
[TBL] [Abstract][Full Text] [Related]
19. Autologous lacrimal-lymphoid mixed-cell reactions induce dacryoadenitis in rabbits.
Guo Z; Song D; Azzarolo AM; Schechter JE; Warren DW; Wood RL; Mircheff AK; Kaslow HR
Exp Eye Res; 2000 Jul; 71(1):23-31. PubMed ID: 10880273
[TBL] [Abstract][Full Text] [Related]
20. Lacrimal gland fluid secretion and lymphocytic infiltration in the NZB/W mouse model of Sjögren's syndrome.
Paranyuk Y; Claros N; Birzgalis A; Moore LC; Brink PR; Walcott B
Curr Eye Res; 2001 Sep; 23(3):199-205. PubMed ID: 11803482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
